Table 2.
Valve13–20 | Coil24–33 | TVA37–39 | ABS42,43 | TLD44,45 | |
---|---|---|---|---|---|
Mechanism | Reducing airway Trapping | Improvement of elastic recoil | Local inflammatory reactions | Blocking Airway | Reduction of bronchoconstriction |
Reversibility | Yes | Partial | No | Partial | No |
Dependence of collateral ventilation | Yes | No | No | Yes | No |
Type of Emphysema | Heterogeneous | Heterogeneous or homogeneous | Heterogeneous, only upper lobe | Homogeneous | Heterogeneous or homogeneous |
Possible relevant complications | Pneumothorax, Dislocation, or migration of Valve | COPD Exacerbation, Pneumonia | Local and systemic inflammatory reactions, Pneumonia or Pneumonitis | Exacerbation, pneumothorax, hemoptysis | Exacerbation, Procedure related |
BLVR: bronchoscopic lung volume reduction; TVA: thermal vapor ablation; LVR: lung volume reduction; TLD: targeted lung denervation; ABS: airway bypass stent